| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 3,5000% | ₹502.25 0% | 3,100 | ₹1.4 0% | 4,0000% |
| - | - | 3,200 | ₹1.5 0% | 1,0000% |
| - | - | 3,250 | ₹2.45 -41.66% | 4,7500% |
| 1,0000% | ₹287.3 0% | 3,300 | ₹3.3 -46.77% | 20,000-12.08% |
| 1,0000% | ₹181.95 0% | 3,350 | ₹5.2 -43.78% | 10,750-15.68% |
| 3,7500% | ₹168 0% | 3,400 | ₹8.55 -43% | 44,000-30.15% |
| 3,250-27.77% | ₹110 8% | 3,450 | ₹15.65 -40.03% | 25,75024.09% |
| 91,750-1.60% | ₹73 6.41% | 3,500 | ₹28.65 -32.9% | 1,03,500-5.47% |
| 1,03,7508.63% | ₹45 1.46% | 3,550 | ₹50.4 -25.33% | 43,75060.55% |
| 1,62,5000.93% | ₹26.45 -0.93% | 3,600 | ₹79.55 -22.04% | 26,500-5.35% |
| 40,000-0.62% | ₹16.4 -1.79% | 3,650 | ₹119.3 -14.6% | 14,000-1.75% |
| 1,24,5001.63% | ₹9.5 -9.52% | 3,700 | ₹152.55 -14.77% | 7,250-3.33% |
| 28,2504.62% | ₹6.2 -11.42% | 3,750 | ₹212.15 -5.58% | 6,25038.88% |
| 46,25014.90% | ₹4.25 -18.26% | 3,800 | ₹260.1 -5.88% | 3,75015.38% |
| 20,500-7.86% | ₹3.45 -11.53% | 3,850 | ₹331 0% | 1,2500% |
| 20,25017.39% | ₹2.5 -15.25% | 3,900 | ₹313.6 0% | 1,5000% |
| 8,5000% | ₹1.6 -45.76% | 3,950 | ₹430.05 0% | 7,7500% |
| 36,500-4.57% | ₹1.65 -5.71% | 4,000 | ₹411 0% | 1,0000% |
| 20,500-1.20% | ₹0.6 -40% | 4,100 | ₹533.3 0% | 10,7500% |
| 8,0000% | ₹0.45 0% | 4,200 | ₹677.4 0% | 6,0000% |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
